Table 2 Numbers of trials by target disease and trial design (RCT or non-RCT)
Target disease | Number of trials | |||
|---|---|---|---|---|
| Â | Total | RCT* | Non-RCT* | |
Ischemic heart disease | 60 | (39.5%) | 39 | 21 |
Hypertension | 34 | (22.4%) | 21 | 13 |
Cerebrovascular disorder | 28 | (18.4%) | 23 | 5 |
Heart failure | 17 | (11.2%) | 12 | 5 |
Hyperlipidemia | 13 | (8.6%) | 9 | 4 |
Diabetes mellitus | 10 | (6.6%) | 9 | 1 |
Chronic kidney disease | 7 | (4.6%) | 5 | 2 |
Arrhythmia | 5 | (3.3%) | 5 | 0 |
Total | 152 | (100%) | 108 | 46 |